Literature DB >> 879763

Comparation interferon- inducing and antiviral properties of 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166), tilorone hydrochloride, and polyinosinic-polycytidylic acid.

D A Stringfellow.   

Abstract

2-Amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166), polyinosinic acid-polycytidylic acid [poly(I:C)], and tilorone HCl induced high levels of serum interferon in mice. Each consequently protected mice against infection with several viruses. After daily injection of inducer, mice developed a reduced interferon response (hyporeactivity) to each compound. However, hyporeactivity developed more slowly to U-25,166 and poly(I:C) than to tilorone HCl. After onset of hyporeactivity, 5 to 6 days without each inducer were required before normal serum interferon levels could be stimulated. Animals also developed a hyporeactive state as a consequence of Semliki Forest or encephalomyocarditis virus infections. By day 2 of either infection, mice had a suppressed interferon response to tilorone HCl, but remains responsive to poly(I:C) or U-25,166 until day 4. In vivo, poly(I:C) stimulated interferon production in a variety of cells and organs, whereas the tilorone HCl and U-25,166 responses involved a nonlymphoid component of the reticuloendothelial system. In vitro, poly(I:C) induced interferon in a variety of murine cells, U-25,166 was active in murine thymus and spleen organ cultures, and tilorone was inactive. These data indicate that U-25,166 is an interesting low-molecular-weight interferon inducer.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 879763      PMCID: PMC352115          DOI: 10.1128/AAC.11.6.984

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Hyporeactivity of infection: potential limitation to therapeutic use of interferon-inducing agents.

Authors:  D A Stringfellow; L A Glasgow
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

2.  Effect of antilymphocytic serum on circulating interferon in mice as a function of the inducer.

Authors:  J de Maeyer-Guignard; E de Maeyer
Journal:  Nat New Biol       Date:  1971-02-17

3.  Inhibition of respiratory virus infection by locally applied interferon.

Authors:  T C Merigan; S E Reed; T S Hall; D A Tyrrell
Journal:  Lancet       Date:  1973-03-17       Impact factor: 79.321

4.  Inducers of interferon and host resistance, V. In vitro studies.

Authors:  A K Field; A A Tytell; G P Lampson; M R Hilleman
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

5.  Toward control of viral infections of man.

Authors:  M R Hilleman
Journal:  Science       Date:  1969-05-02       Impact factor: 47.728

6.  Stimulation of murine interferon by a substituted pyrimidine.

Authors:  F R Nichol; S D Weed; G E Underwood
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

7.  Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis.

Authors:  H B Greenberg; R B Pollard; L I Lutwick; P B Gregory; W S Robinson; T C Merigan
Journal:  N Engl J Med       Date:  1976-09-02       Impact factor: 91.245

8.  Interferon synthesis in x-irradiated animals v. Origin of mouse serum interferon induced by polyinosinic-polycytidylic Acid and encephalomyocarditis virus.

Authors:  P Jullien; J De Maeyer-Guignard; E De Maeyer
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

9.  Tilorone hydrochloride: an orally active antiviral agent.

Authors:  R E Krueger; G D Mayer
Journal:  Science       Date:  1970-09-18       Impact factor: 47.728

10.  Tilorone hydrochloride: mode of action.

Authors:  G D Mayer; R F Krueger
Journal:  Science       Date:  1970-09-18       Impact factor: 47.728

View more
  9 in total

1.  Efficacy of Tilorone Dihydrochloride against Ebola Virus Infection.

Authors:  Sean Ekins; Mary A Lingerfelt; Jason E Comer; Alexander N Freiberg; Jon C Mirsalis; Kathleen O'Loughlin; Anush Harutyunyan; Claire McFarlane; Carol E Green; Peter B Madrid
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

2.  Structure-activity relationships in human toll-like receptor 7-active imidazoquinoline analogues.

Authors:  Nikunj M Shukla; Subbalakshmi S Malladi; Cole A Mutz; Rajalakshmi Balakrishna; Sunil A David
Journal:  J Med Chem       Date:  2010-06-10       Impact factor: 7.446

3.  Effect of pyrimidinone treatment on lethal and immunosuppressive murine cytomegalovirus infection.

Authors:  R J Brideau; J A Wolcott
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

4.  STING agonists induce an innate antiviral immune response against hepatitis B virus.

Authors:  Fang Guo; Yanxing Han; Xuesen Zhao; Jianghua Wang; Fei Liu; Chunxiao Xu; Lai Wei; Jian-Dong Jiang; Timothy M Block; Ju-Tao Guo; Jinhong Chang
Journal:  Antimicrob Agents Chemother       Date:  2014-12-15       Impact factor: 5.191

5.  Toll-like receptor-8 agonistic activities in C2, C4, and C8 modified thiazolo[4,5-c]quinolines.

Authors:  Hari Prasad Kokatla; Euna Yoo; Deepak B Salunke; Diptesh Sil; Cameron F Ng; Rajalakshmi Balakrishna; Subbalakshmi S Malladi; Lauren M Fox; Sunil A David
Journal:  Org Biomol Chem       Date:  2013-02-21       Impact factor: 3.876

6.  Antiviral and interferon-inducing properties of 1,5-diamino anthraquinones.

Authors:  D A Stringfellow; S D Weed; G E Underwood
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

7.  Structure-activity relationships in human Toll-like receptor 8-active 2,3-diamino-furo[2,3-c]pyridines.

Authors:  Deepak B Salunke; Euna Yoo; Nikunj M Shukla; Rajalakshmi Balakrishna; Subbalakshmi S Malladi; Katelyn J Serafin; Victor W Day; Xinkun Wang; Sunil A David
Journal:  J Med Chem       Date:  2012-09-07       Impact factor: 7.446

8.  Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice.

Authors:  D F Smee; J H Huffman; A C Gessaman; J W Huggins; R W Sidwell
Journal:  Antiviral Res       Date:  1991 Mar-Apr       Impact factor: 5.970

9.  Machine learning models identify molecules active against the Ebola virus in vitro.

Authors:  Sean Ekins; Joel S Freundlich; Alex M Clark; Manu Anantpadma; Robert A Davey; Peter Madrid
Journal:  F1000Res       Date:  2015-10-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.